Winnergy Medical PCL (BKK:WINMED)
1.180
+0.010 (0.85%)
Apr 25, 2025, 4:27 PM ICT
Winnergy Medical PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Revenue | 654.36 | 639.18 | 703.41 | 538.64 | 530.54 | Upgrade
|
Revenue Growth (YoY) | 2.37% | -9.13% | 30.59% | 1.53% | 7.75% | Upgrade
|
Cost of Revenue | 386.08 | 380.75 | 441.55 | 295.37 | 283.2 | Upgrade
|
Gross Profit | 268.27 | 258.43 | 261.87 | 243.27 | 247.34 | Upgrade
|
Selling, General & Admin | 243.8 | 221.37 | 203.68 | 186.24 | 177.86 | Upgrade
|
Operating Expenses | 243.8 | 221.37 | 203.68 | 186.24 | 177.86 | Upgrade
|
Operating Income | 24.47 | 37.06 | 58.18 | 57.03 | 69.48 | Upgrade
|
Interest Expense | -12.17 | -9.07 | -6.87 | -4.94 | -8.05 | Upgrade
|
Interest & Investment Income | 2.66 | 4.68 | 16.1 | 17.56 | 0 | Upgrade
|
Currency Exchange Gain (Loss) | 1.14 | 0.83 | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 1.12 | 1.76 | 1.66 | 0.78 | 0.51 | Upgrade
|
EBT Excluding Unusual Items | 17.22 | 35.25 | 69.07 | 70.44 | 61.94 | Upgrade
|
Gain (Loss) on Sale of Assets | 12.19 | - | - | - | - | Upgrade
|
Other Unusual Items | 4.57 | - | 0.45 | 1.73 | - | Upgrade
|
Pretax Income | 33.97 | 35.25 | 69.52 | 72.16 | 61.94 | Upgrade
|
Income Tax Expense | 4.71 | 4.61 | 8.85 | 6.96 | 10.35 | Upgrade
|
Net Income | 29.26 | 30.64 | 60.67 | 65.21 | 51.59 | Upgrade
|
Net Income to Common | 29.26 | 30.64 | 60.67 | 65.21 | 51.59 | Upgrade
|
Net Income Growth | -4.50% | -49.50% | -6.96% | 26.39% | 13.96% | Upgrade
|
Shares Outstanding (Basic) | 400 | 400 | 400 | 359 | 163 | Upgrade
|
Shares Outstanding (Diluted) | 400 | 400 | 400 | 359 | 163 | Upgrade
|
Shares Change (YoY) | - | - | 11.55% | 119.55% | 48.48% | Upgrade
|
EPS (Basic) | 0.07 | 0.08 | 0.15 | 0.18 | 0.32 | Upgrade
|
EPS (Diluted) | 0.07 | 0.08 | 0.15 | 0.18 | 0.32 | Upgrade
|
EPS Growth | -4.50% | -49.50% | -16.59% | -42.43% | -23.24% | Upgrade
|
Free Cash Flow | -67.37 | -46.1 | -131.78 | -48.66 | -30.82 | Upgrade
|
Free Cash Flow Per Share | -0.17 | -0.12 | -0.33 | -0.14 | -0.19 | Upgrade
|
Dividend Per Share | 0.025 | 0.029 | 0.057 | 0.065 | 0.149 | Upgrade
|
Dividend Growth | -16.10% | -48.16% | -12.46% | -56.35% | -98.18% | Upgrade
|
Gross Margin | 41.00% | 40.43% | 37.23% | 45.16% | 46.62% | Upgrade
|
Operating Margin | 3.74% | 5.80% | 8.27% | 10.59% | 13.10% | Upgrade
|
Profit Margin | 4.47% | 4.79% | 8.63% | 12.11% | 9.72% | Upgrade
|
Free Cash Flow Margin | -10.29% | -7.21% | -18.73% | -9.03% | -5.81% | Upgrade
|
EBITDA | 65.05 | 75.7 | 93.15 | 82.45 | 86.82 | Upgrade
|
EBITDA Margin | 9.94% | 11.84% | 13.24% | 15.31% | 16.36% | Upgrade
|
D&A For EBITDA | 40.58 | 38.64 | 34.96 | 25.41 | 17.34 | Upgrade
|
EBIT | 24.47 | 37.06 | 58.18 | 57.03 | 69.48 | Upgrade
|
EBIT Margin | 3.74% | 5.80% | 8.27% | 10.59% | 13.10% | Upgrade
|
Effective Tax Rate | 13.88% | 13.09% | 12.73% | 9.64% | 16.71% | Upgrade
|
Revenue as Reported | 654.36 | 639.18 | 703.41 | 538.64 | 530.54 | Upgrade
|
Advertising Expenses | 17.18 | 17.26 | 18.95 | 12.5 | 10.63 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.